RecruitingNCT06952881

A Study on COPD Phenotypes, Endotypes and Treatable Traits


Sponsor

Chinese University of Hong Kong

Enrollment

460 participants

Start Date

May 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and multisystemic disease with progressive increasing morbidity and mortality. COPD is now widely accepted as a heterogeneous condition with multiple phenotypes and endotypes.The recognition of COPD phenotypes and endotypes has significantly impacted the management of the disease. Furthermore, treatable traits (TTs) are recognizable phenotypic or endotypic characteristics that can be assessed and successfully targeted by therapy to improve a clinical outcome in a patient with airway disease. The healthcare system in Hong Kong is different from that of other places. Previous studies in Hong Kong only looked at specific endotypes; an example is the eosinophils cut-off to predict COPD exacerbations and the treatment effect of applying interventions to certain phenotypes, e.g. approaching the exacerbation phenotype with a comprehensive care programme. There is not much information on the overall phenotypes, endotypes, and TTs of COPD patients in Hong Kong. The characteristics of the patients would help to further assess whether the multi-TT approach can improve their outcomes. This study aims to assess 1. the phenotypes, endotypes and treatable traits of COPD patients over time 2. Outcome of patients according to their phenotypes, endotypes and treatable traits over a period of 3 years. 4\) Clustering analyses will also be employed to assess groups of patients with similar characteristics and to assess the change in their outcome over time.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study aims to better understand COPD (Chronic Obstructive Pulmonary Disease) — a lung condition that makes breathing difficult. Researchers want to identify different types and patterns of COPD to improve how it is diagnosed and treated individually. **You may be eligible if...** - You are 40 years or older - You have been diagnosed with COPD based on breathing test results and ongoing respiratory symptoms such as breathlessness, cough, or mucus production **You may NOT be eligible if...** - You have a serious illness (such as advanced cancer or severe heart or kidney failure) that would prevent you from being followed up over 3 years - You are unable to provide written consent to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06952881


Related Trials